Omni-PAGE?預(yu)制膠(Hepes-Tris)
Omni-PAGE?Hepes-Tris Gels
本產品常溫運輸;4℃可保存18個月。切勿置于0℃以下,以免凝膠發生凍裂。
產品組分
產品特點
go
o穩定性高——采用自動化灌(guan)膠生產(chan)技(ji)術,確保了產(chan)品質量的高穩定性和(he)重復性;
go
o晰——采用玻璃膠板,有效減少蛋白(bai)非特(te)異性吸附(fu),使蛋白(bai)條帶更(geng)為尖銳,清晰(xi);
go
o電泳快速——電泳時間短(duan),在150V電(dian)壓下,電(dian)泳40~50min即可完成;
go
o操作簡便——膠夾打(da)開(kai)極為(wei)輕(qing)松,只需用刀片在膠夾一(yi)側輕(qing)輕(qing)劃一(yi)下即可打(da)開(kai);
go
o通用性強——凝(ning)膠中(zhong)不(bu)含SDS,可用于(yu)變(bian)性(xing)和非變(bian)性(xing)電(dian)泳(需使(shi)用非變(bian)性(xing)電(dian)泳液);
go
o兼容性強——兼容(rong)市場上主(zhu)流的mini電泳槽,如Bio-Rad,Invitrogen,天能和君意東方等;
go
o種類多樣——提供多種濃度的均(jun)一(yi)膠和梯度膠。均(jun)一(yi)膠可選濃度:8%,10%,12%,15%。梯度(du)膠可選濃度(du):4~15%,4~20%,8~20%。
產(chan)品(pin)簡介(jie)
goodOmni-PAGE?預(yu)制(zhi)膠(jiao)(Hepes-Tris)是一款安全、快捷、高性能的預(yu)制聚(ju)丙烯酰胺凝膠,常用于PAGE和Western Blot檢測。本預制(zhi)膠含有1.5cm高度的4%濃縮(suo)膠。丙烯酰(xian)(xian)胺與甲叉雙丙烯酰(xian)(xian)胺的比例為(wei)29:1,凝膠厚度(du)為1.5mm,加樣孔數(shu)為10孔/15孔,最大(da)上樣量(liang)為(wei)60μL/30μL,膠板尺寸:寬×高×厚度為(wei)98×84×4.1mm;凝膠(jiao)尺寸為:寬×高×厚度為81 × 74×1.5mm。
1. Mei, J., Zhou, W. J., Zhu, X. Y., Lu, H., Wu, K., Yang, H. L., ... & Wang, J. (2018). Suppression of autophagy and HCK signaling promotes PTGS2high FCGR3? NK cell differentiation triggered by ectopic endometrial stromal cells. Autophagy, 14(8), 1376-1397. (IF 16.016)
good2. Ji, L., Qian, W., Gui, L., Ji, Z., Yin, P., Lin, G. N., ... & Gao, W. Q. (2020). Blockade of β-Catenin–Induced CCL28 Suppresses Gastric Cancer Progression via Inhibition of Treg Cell Infiltration. Cancer Research, 80(10), 2004-2016. (IF 12.701)
good3. LI, Jing, et al. Selenium Status in Diet Affects Acetaminophen-Induced Hepatotoxicity via Interruption of Redox Environment. Antioxidants & Redox Signaling, 2021, 34.17: 1355-1367.(IF 8.401)
good4. Li, J., Cheng, P., Li, S., Zhao, P., Han, B., Ren, X., ... & Lu, J. (2020). Selenium status in diet affects acetaminophen-induced hepatotoxicity via interruption of redox environment. Antioxidants and Redox Signaling, (ja). (IF 8.401)
good5. LIU, Suxian, et al. Uncovering the Mechanism of Curcuma in the Treatment of Ulcerative Colitis Based on Network Pharmacology, Molecular Docking Technology, and Experiment Verification. Evidence-Based Complementary and Alternative Medicine, 2021, 2021.(IF 2.629)